Literature DB >> 8745018

Correlation of tuberculin induration with the number of Bacillus Calmette-Guérin vaccines.

I Ildirim1, M Hacimustafaoğlu, B Ediz.   

Abstract

In developing countries with a higher prevalence of tuberculous infection, usually more than one Bacillus Calmette-Guérin (BCG) vaccine is recommended. Revaccination can considerably alter the tuberculin skin test response and the diagnosis of tuberculous infection. In this study to assess the relationship between the number of BCG vaccinations and tuberculin skin reactions, 3548 children (ages 6 to 12 years) from 7 elementary schools were given 5 tuberculin units of purified protein derivative, and results were compared taking vaccination status into account. Forty-seven children were excluded from the study. Mean purified protein derivative induration size at 72 hours was 3.2 +/- 3.9 mm with no BCG scar (n = 1518), 6.3 +/- 7.8 mm with 1 scar (n = 1513), 10.7 +/- 6.2 mm with 2 scars (n = 433) and 14.8 +/- 4.3 mm with 3 scars (n = 37). In children with no scar the 90th percentile values of the size of the purified protein derivative induration were 10 mm. The 90th percentile values of children with one, two and three scars were 15, 17.5 and 20 mm, respectively. We suggest that tuberculin skin test responses be evaluated with regard to the number of previous BCG vaccinations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8745018     DOI: 10.1097/00006454-199512000-00006

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  10 in total

1.  Predictive value of a 24 hour tuberculin skin test evaluation.

Authors:  F Oztürk; M Eskiocak; A Bay; R Sancak; S Dabak; N Gürses
Journal:  Arch Dis Child       Date:  1997-05       Impact factor: 3.791

2.  BCG revaccination and tuberculin reactivity.

Authors:  N Kuyucu; S Kuyucu; A Bakirtas; C Karacan
Journal:  Indian J Pediatr       Date:  2001-01       Impact factor: 1.967

3.  Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis.

Authors:  P D Johnson; R L Stuart; M L Grayson; D Olden; A Clancy; P Ravn; P Andersen; W J Britton; J S Rothel
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

4.  Tuberculosis skin testing, anergy and protein malnutrition in Peru.

Authors:  T F Pelly; C F Santillan; R H Gilman; L Z Cabrera; E Garcia; C Vidal; M J Zimic; D A J Moore; C A Evans
Journal:  Int J Tuberc Lung Dis       Date:  2005-09       Impact factor: 2.373

5.  A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements.

Authors:  L Wang; M O Turner; R K Elwood; M Schulzer; J M FitzGerald
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

6.  The tuberculin skin test (TST) is affected by recent BCG vaccination but not by exposure to non-tuberculosis mycobacteria (NTM) during early life.

Authors:  Sarah Burl; Uche J Adetifa; Momodou Cox; Ebrima Touray; Hilton Whittle; Helen McShane; Sarah L Rowland-Jones; Katie L Flanagan
Journal:  PLoS One       Date:  2010-08-19       Impact factor: 3.240

7.  The value of counting BCG scars for interpretation of tuberculin skin tests in a tuberculosis hyperendemic shantytown, Peru.

Authors:  M Saito; C T Bautista; R H Gilman; A Bowering; M Z Levy; C A Evans
Journal:  Int J Tuberc Lung Dis       Date:  2004-07       Impact factor: 2.373

8.  The clinical utility of tuberculin skin test and interferon-γ release assay in the diagnosis of active tuberculosis among young adults: a prospective observational study.

Authors:  Ji Eun Lee; Hee-Jin Kim; Sei Won Lee
Journal:  BMC Infect Dis       Date:  2011-04-18       Impact factor: 3.090

9.  Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau.

Authors:  Adam Edvin Roth; Christine Stabell Benn; Henrik Ravn; Amabelia Rodrigues; Ida Maria Lisse; Maria Yazdanbakhsh; Hilton Whittle; Peter Aaby
Journal:  BMJ       Date:  2010-03-15

10.  Tuberculin skin test distribution following a change in BCG vaccination policy.

Authors:  Sei Won Lee; Soo Yeon Oh; Jin Beom Lee; Chang Min Choi; Hee Jin Kim
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.